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Summary
Background Endotoxins are common contaminants in allergen preparations and affect
antigen-speciﬁc cellular responses. Distinct effects of endotoxin on cells in human umbilical
cord and adult blood are poorly deﬁned.
Objectives To examine the effect of endotoxins in allergen preparations on cellular responses
in human cord and peripheral blood (PB).
Methods The endotoxin content in b lactoglobulin (BLG), the peanut allergen Ara h 1 and the
major birch pollen allergen Bet v 1 was assessed. Proliferation and cytokine response of
mononuclear cells towards contaminated and lipopolysaccharide (LPS)-free allergens were
evaluated at different time-points. Fractions of contaminated BLG were generated and
assayed on their immuno-stimulatory capacity. The involvement of toll-like receptor (TLR) 2
and 4 was investigated by blocking antibodies and TLR-transfected human embryonic kidney
cells.
Results The proliferative response of cord blood (CB)-derived mononuclear cells towards
allergen-preparations at day 3 was related to the level of LPS contamination. At day 7,
proliferation was also detected in the absence of endotoxin. Cytokine production in CB was
strongly affected by the content of endotoxin, TLR-4 dependent and not related to the
allergen content. Allergen- and endotoxin-induced proliferative responses were generally
signiﬁcantly higher in CB than in adult blood.
Conclusion Endotoxins in allergen preparations confound allergen-speciﬁc cellular
responses. The impact of these contaminations varies with the blood source (CB vs. PB), the
type of allergen and is time- and dose-dependent.
Keywords cord blood, endotoxin contamination, food allergens, T-cells, toll like receptors
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Introduction
Endotoxins in antigen preparations are a potential con-
founder in in vitro cellular assays [1, 2]. Lipopolysacchar-
ide (LPS) contaminations play a role in daily laboratory
practice. The milk-derived whey protein b lactoglobulin
(BLG) is a prominent food antigen often used as a model
allergen. High endotoxin contamination of commercially
available formulations has been described [3]. The efﬁ-
cacy of removal procedures is limited. Residual endotoxin
often remains present in amounts that might affect
lymphoproliferation and cytokine production. LPS in
allergen preparations has been shown to modulate cellular
responses in animal studies [3, 4]. In these experimental
models, the relevance of endotoxin-contamination
seemed to vary with the time-point of exposure (prenatal,
postnatal, adult animal). In humans, and in particular in
cord blood (CB), the effects of endotoxin-contamination
on allergen-speciﬁc cellular proliferation and cytokine
production are poorly deﬁned.
Immunostimulatory effects of LPS-contaminated al-
lergen preparations on cord blood mononuclear cells
(CBMCs) are particularly relevant, because large efforts
have been made to predict the development of allergy on
the basis of in vitro allergen-speciﬁc proliferation of
CBMC [5, 6].
Basic Mechanisms in Allergic Disease
 
EC
1These authors contributed equally
doi: 10.1111/j.1365-2222.2008.03080.x Clinical and Experimental Allergy, 38, 1627–1634
  c 2008 The Authors
Journal compilation   c 2008 Blackwell Publishing LtdNumerous reports indicate the presence of fetal T cells
responsive to food and inhalant allergens in CB [5–17].
The priming of CB cells has been linked to prenatal
antigen transfer [7, 9–12, 14–24]. It seems, however, that
CB proliferative responses do not correlate with the
amount of maternal allergen exposure [7]. In addition, up
to 90% of CB preparations showed proliferation to BLG
in vitro, which is higher than proliferative responses
towards other allergens [11, 14, 19]. Thus, the physiologi-
cal relevance of CB immune responses and their under-
lying mechanisms areunder debate [25, 26]. Itis, however,
possible, that LPS in allergen preparations contribute to
proliferative responses in CB and confound allergen-
speciﬁc effects.
The aim of the present study was to examine the impact
of endotoxins in commercially available allergen prepara-
tions on allergen-speciﬁc cellular responses. In particular,
we aimed to investigate the differential confounding
actions of endotoxins in a ‘naı ¨ve’ (CB) and a mature
system (peripheral blood (PB) of adult individuals).
Here we demonstrate that endotoxin contamination in
commercially available BLG preparations largely, but not
exclusively, causes cellular proliferation and cytokine
production in human CB cells. Effects of LPS were toll-like
receptor (TLR)-4 dependent. Allergen- and endotoxin-
induced proliferative responses were generally signiﬁ-
cantly higher in CB than in adult blood.
Material and methods
Allergen preparations
Endotoxin levels of the antigen preparations used in this
study were quantiﬁed by limulus amoeboid lysate assay
(Cambrex Bio Science, Walkersville, MD, USA; limit of
detection 0.035EU/mL) according to the manufacturer’s
instructions.
The following BLG preparations were used: BLG 3908
and L-0130 [BLG (NP), Sigma Sciences, St Louis, MO,USA]
were contaminated with endotoxins (515 and 118EU/mL,
Table S1, online repository, 490% BLG). LPS-free BLG
[BLG (LF), PSDI-2400, produced from bovine whey pro-
tein isolate, Arla Food, Arhus, Denmark, 495% BLG]
contained 0.96EU (Table S1) [3]. Fractions of BLG L-0130
[BLG (NP)] were obtained by size exclusion chromatogra-
phy (SEC) as described by Brix et al. [3]. Brieﬂy, BLG [NP]
was dissolved in ammonium acetate (0.15 M, pH 6.0 at
20mg/mL) and 5mL were applied to a Superdex 75
column (Hiload 26/60, AP biotech, Uppsala, Sweden).
Elution was carried out using the same buffer at 2.5mL/
min. Fractions of 10mL were collected and frozen. Before
inclusion in cell cultures, 2 1mL from each fraction was
vacuum dried, and twice evaporated with distilled water
to remove any residuals of eluting buffer. The effects of all
SEC-purified BLG fractions on murine leucocytes have
previously been described by Brix et al. [3].
Puriﬁed, endotoxin-free Ara h 1, was provided by
Dr E. N. Mills, (IFR Norwich, UK, o0.035EU/mL). Recom-
binant Betula verrucosa allergen, Bet v 1, was purchased
(Biomay, Vienna, Austria), and contained 1.96EU/mL.
Tetanus toxoid (tt) was purchased from Calbiochem (San
Diego, CA, USA; 0.55EU/mL).
Cord blood and peripheral blood mononuclear cells
The study protocol was approved by the local Ethics
Committee of the Medical University of Vienna. Human
umbilical CB from randomly chosen full-term healthy
infants (437 weeks of gestation) was obtained by veno-
puncture of the umbilical vein immediately after delivery
and placed in sterile sodium heparin tubes. Adult volun-
teers with no history of food allergy and no sensitizations
(speciﬁc IgEo0,35kU/L, skin prick test negative) were
used as controls. Heparinized blood was drawn over
Ficoll-Paque (Pharmacia, Uppsala, Sweden). Mononuclear
cells were isolated by density-gradient centrifugation as
described [19].
Proliferation assays
Proliferation of CBMCs and peripheral blood mononuclear
cells (PBMCs) towards allergens and LPS was determines
by
3[H]thymidine incorporation assay. According to the
literature, an SI42 was considered positive [15].
Cytokine measurement
CBMCs were co-cultured with the respective antigen at
5 10
5/mL ultra culture complete ultra culture medium
(UCC, Biowhittaker, Walkersville, MD, USA) supplemented
with 2mML -glutamine and 170mg/L gentamycin sul-
phate (Sigma Sciences) in 96-well round-bottom plates in
triplicates.
Unstimulated cells served as negative control. Super-
natants were harvested at days 3 and 7 and frozen at
 70 1C in cryotubes. IL-1b, IL-5, IL-10, TNF-a and INF-g
levels were measured by cytometric bead array (Flex Kit,
Becton Dickinson, San Jos´ e, CA, USA) using a FACS Canto
(Becton Dickinson) according to the instructions provided
by the manufacturer.
Toll-like receptor 2 and toll-like receptor 4 transfected
human embryonic kidney cells (HEK293)
HEK293, stably transfected with human CD14 (293-
hCD14), CD14 and TLR2 (293-hCD14/TLR2), or CD14 and
TLR4 (293-hCD14/TLR4) were kindly provided by Prof. M.
Yazdanbakhsh (Leiden University Medical Center, the
Netherlands). Cells were cultured in standard Dulbecco’s
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Pasching, Austria) containing 10% fetal bovine serum,
gentamycine sulphate (0.1mg/mL; Sigma Sciences) puro-
mycin (5mg/mL, Sigma Sciences) for 24h. For stimulation
experiments, 4 10
4 cells/well were placed in 96-well
ﬂat-bottom plates (Costar) in complete medium and co-
incubated with the indicated antigens at 371Ci n5 %C O 2
for 4 days. Thereafter cell-free supernatants for cytokine
measurements were collected. Untreated cells served as
control. For stimulation of 293-hCD14/TLR4 cells, MD2
supernatant (a kind gift of Prof. M. Yazdanbakhsh, Leiden
University Medical Center, the Netherlands) was added to
the culture medium. The concentration of IL-8 in the
supernatant was measured by ELISA (Thermo scientiﬁc,
Rockford, IL, USA; limit of detection 25.6pg/mL) accord-
ing to the manufacturer’s instruction.
Toll-like receptor-inhibition assays
Cord blood-derived monocytes were isolated via adher-
ence in 48-well ﬂat-bottom well plates. Cells were pre-
treated with 1mg/mL blocking anti-TLR-4 monoclonal
mouse anti human antibody or isotype control (IgG2a, all
from eBioscience, San Diego, CA, USA) for 1h, before
allergen preparations or LPS (positive control) were added
for 6h. Cell-free supernatant was obtained and stored at
 70 1C. TNF-a was measured by ELISA (Bender MedSys-
tems, Vienna, Austria, limit of detection 7.8pg/mL).
Statistics
Data were analyzed using SPSS 11.0.1 for Windows
(SPSS Inc., Chicago, IL, USA). Non-parametric Wilcoxon’s
signed rank test was applied for matched pairs and
Mann–Whitney U-test was used for independent sam-
ples. When Gaussian distribution was given, the Student
t-test for independent samples or matched pairs t-test
were performed. P-values of o0.05 were considered
signiﬁcant.
Results
Unpuriﬁed antigen preparations of b lactoglobulin
confound proliferative and cytokine responses of cord and
adult blood-derived mononuclear cells
Using limulus amoeboid lysate assay, we conﬁrmed pre-
vious ﬁndings of high amounts of endotoxins present
in commercially available BLG preparations [3] (online
repository, Table S1). Puriﬁcation via polymyxin B col-
umns substantially reduced the endotoxin content of
these preparations, but considerable amounts of endotox-
in remained detectable (online repository, Table S1). The
major peanut allergen Ara h 1 was endotoxin free. In
initial experiments, we determined times of maximum
CBMC-proliferation to endotoxin and allergen, respec-
tively, as well as cut-off levels for LPS responses. We
found that day 3 reﬂected endotoxin-related proliferation
whereas day 7 most reliably was conﬁned to allergen-
speciﬁc responses (data not shown). Dose titration experi-
ments with LPS revealed a cut-off level of around 1ng
LPS ( 10EU) inducing a positive stimulation index 42
and 0.07ng ( 0.7EU) inducing TNF-a production above
the limit of detection at day 3, and above baseline TNF-a
production at day 7 in CB (online repository, Fig. S1).
We next performed dose allergen titration experiments
from 0.1 to 50mg/mL and the puriﬁed allergen spiked with
the corresponding endotoxin doses to deﬁne the differ-
ential impact of allergen and endotoxin. At day 3, CBMCs
proliferated in response to unpuriﬁed, but not to puriﬁed
BLG [BLG (LF), (Po0.05; Wilcoxon’s signed rank test,
Fig. 1]. At day 7 though, the puriﬁed allergen [BLG (LF)]
also induced proliferation (Fig. 1). The amount of BLG
[NP] proliferation was signiﬁcantly enhanced at a con-
centration of 0.1–5mg/mL and remained borderline sig-
niﬁcant at a concentration of 10–50mg/mL (P=0.063).
Addition of LPS at levels similar to those present in the
unpuriﬁed BLG [BLG (NP)] to the uncontaminated aller-
gen preparation [BLG (LF)] restored the proliferative
response (Fig. 1). Lymphoproliferation towards the endo-
toxin-free Ara h 1 could equally be spiked by addition of
endotoxin (Fig. 1).
The impact of lipopolysaccharide on tetanus toxoid- and
Bet v 1-speciﬁc proliferation
To control for naturally occurring proliferative responses
in vaccinated adult individuals the recall antigen TT was
tested. The TT preparation used herein contained also
endotoxin, but below the limit of relevance (online
repository, Table S1). A dose of 1mg/mL TT was spiked
with increasing levels of endotoxin corresponding to the
amount of contamination measured in unpuriﬁed BLG.
Doing so, a signiﬁcantly increased proliferative response
of PBMCs at day 7 was induced as compared with
unspiked TT alone (Fig. 2, red lines).
In order to evaluate the relevance of endotoxin con-
tamination in response to an inhalant allergen, the re-
combinant major birch pollen allergen Bet v 1 was chosen.
CBMCs and PBMCs of non-allergic donors were stimu-
lated with titrated concentrations of rBet v 1 in the range
of 0.1–50mg/mL. No proliferative responses were detected
in CBMCs (Fig. 3a, black line) whereas rBet v 1 induced
proliferation in PBMCs from 3/6 donors (Fig. 3a, red line).
However, when PBMCs and CBMCs were stimulated
with 10mg of rBet v 1 and increasing concentrations of
LPS, already the presence of 200pgLPS/mL signiﬁcantly
increased proliferation of CBMCs (Po0.05). In PBMCs in
contrast, although a trend towards an impact of LPS was
observed, added concentrations from 200pg to 200ng
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(Fig. 3b).
The proliferative response of cord blood cells to b
lactoglobulin and b lactoglobulin plus endotoxins exceeds
the corresponding response of adult blood cells
The proliferative response to the same amount of endo-
toxins and allergen was compared between cord and
peripheral adult blood. In all experiments, CBMCs showed
a signiﬁcantly higher proliferative response to the pur-
iﬁed allergen [BLG (LF)], as well as to allergen1LPS
[applied in corresponding doses to the per se contami-
nated allergen BLG (NP) (Fig. 4)]. Again, the distinct
inﬂuence of endotoxin on proliferation was detectable in
cord and peripheral adult blood (Fig. 4).
Fig. 2. Low level contaminants affect proliferative response to Th-1 type
recall antigens at day seven in adult individuals. Tetanus toxoid was
applied at a constant concentration of 1mg/mL and LPS was added
according to the amount present in contaminated BLG [NP]. While low-
level contaminants (0.35–35ng/mL) signiﬁcantly increased proliferative
responses to the antigen at day 7 (red lines) this was not detectable in the
presence of higher endotoxin contamination (350ng/mL). At day 3
(black lines) no effect on the readout parameters was measurable. Graph
indicates the mean and the standard error of the mean (n=6). LPS,
lipopolysaccharide; Th-1, T-helper type 1; BLG, b lactoglobulin.
Fig. 3. Allergen-speciﬁc proliferation of adult and cord blood derived
mononuclear cells to the major birch pollen allergen Bet v 1. Cord blood
(CB) and peripheral blood (PB)-derived mononuclear cells were co-
cultured for 3 and 7 days with the recombinant major birch pollen
allergen Bet v 1 (20pg endotoxin/10mg rBet v 1) (a). Three out of six
PBMC samples proliferated in the presence of the allergen at a concen-
tration of 10mg/mL. None of the CB-derived samples did so (0/6).
Contamination at the relevant concentration of 10mg/mL did not affect
proliferation, neither in CB nor in adult blood (b). (n=6 independent
experiments CB and PB; results are expressed as mean SEM). PBMCs,
peripheral blood mononuclear cells.
Fig. 1. Food allergen-speciﬁc proliferation of cord blood derived mono-
nuclear cells. Cord blood-derived mononuclear cells were co-cultured
with different food allergens (BLG, Ara h 1) either in its contaminated
form BLG[NP], its puriﬁed form [BLG(LP), Ara h 1] or with LPS added
according to the degree of contamination present in the respective
concentration of the contaminated allergen [BLG(NP)]. (BLG: n=13;
mean SEM; Ara h 1: n=7 mean SEM; Po0.05 puriﬁed allergen1
LPS vs. puriﬁed allergen;
#Po0.05 contaminated allergen vs. puriﬁed
allergen1LPS; &, contaminated allergen vs. puriﬁed allergen). BLG, b
lactoglobulin; LPS, lipopolysaccharide.
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lactoglobulin relate to high molecular weight fractions and
act via a toll-like receptor 4 dependent mechanism
To determine the size of immuno-reactive components
within the contaminated BLG samples [BLG (NP)], SEC
was performed and 18 sub-fractions were sampled. At day
3, only the high molecular weight fraction, likely to
represent the endotoxin-fraction (F1, F2), induced a
positive proliferative response (Fig. 5a, upper panel),
whereas at day 7 the BLG-corresponding fraction (F5 and
F6, putatively representing BLG dimers) also induced
clonal expansion (Fig. 5a, lower panel). This ﬁnding is in
accordance with our previous experiments. Extremely low
amounts of LPS-induced positive proliferative responses
(Fig. 5b). Assuming a BLG-content of more than 90%, an
at least  100-fold higher potency can be attributed to the
high molecular weight, endotoxin-contaminated fraction.
Puriﬁed BLG (LF) and the BLG-corresponding fractions
(F5, F6) did not induce substantial cytokine production
(online repository, Fig. S1). In contrast, the contaminated
BLG-stimulated cytokine production at very low doses
suggesting an innate immunity driven response corre-
sponding to the LPS-titration results.
To prove the involvement of the most prominent
receptors of endotoxins and to delineate whether LPS is
mainly responsible for the described effects, TLR2 and
TLR4 transfected HEK-cells were generated. Contaminated
BLG initiated a robust IL-8 response via a TLR4 dependent
mechanism (Fig. 6a) but had no effect in TLR2 transfected
cells (Fig. 6b). To further investigate the relevance of TLR-
4i na nin vitro system with all innate immunity receptors
co-expressed, inhibition assays with anti-TLR4 antibodies
were performed. Ultra pure LPS (S. minnesota; stem
Fig. 4. Proliferative responses to allergen and allergen plus endotoxin are
signiﬁcantly higher in cord blood (CB) than in peripheral blood (PB) from
adult donors. The impact of endotoxin contamination is signiﬁcantly
stronger in CB as compared with PB from adult donors (CB: n=17; PB:
n=10). Graph indicates the mean and the standard error of the mean. BLG,
b lactoglobulin;LPS, lipopolysaccharide.
Fig. 5. High molecular weight fragments from unpuriﬁed BLG led to BLG
independent proliferation. High molecular weight fragments isolated by
size exclusion chromatography led to a BLG-independent proliferative
response of CBMCs (a;
#Po0.05; Wilcoxon’s signed rank test). Dose
response experiments of high molecular contaminants and dimeric BLG
revealed, despite of 490% purity of the BLG preparation, a more than
10-times higher potency of the contaminants (b). Dots represent data
from seven independent experiments (Po0.05; Wilcoxon’s signed rank
test). BLG, b lactoglobulin; CBMCs, cord blood mononuclear cells.
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ated via SEC were tested. Ultra-pure LPS-induced TNF-a
production was substantially inhibited by TLR4 blockade
(Fig. 6c). No TNF-a production was induced by BLG [LF].
The high molecular weight fraction (F1; Fig. 6c) acted via
TLR4 while the putative BLG-dimer (F5) did not induce
TNF-a production (Fig. 6c).
Discussion
This study demonstrates that endotoxin in commercially
available antigen preparations strongly affects in vitro
cellular parameters. Endotoxins signiﬁcantly increased
proliferative responses and cytokine production of mono-
nuclear cells towards BLG and the major birch pollen
allergen Bet v 1. Comparable effects were detected when
LPS was added to the more T-helper type 1-type recall
antigen tt. LPS-contamination of the model allergen BLG
led to TLR4 engagement. We further observed that CB-
derived mononuclear cells were more sensitive than
mononuclear cells from adults in terms of proliferative
responses to both, puriﬁed allergens and allergen plus
endotoxins.
Brix et al. proved in mice that the endotoxin fraction of
contaminated BLG is more important in inducing prolif-
eration of naı ¨ve Tcells than the allergen fraction itself [3].
Human CB mainly harbours naı ¨ve T cells and therefore
represents a perfect model system to assess the impact of
endotoxins in BLG on naı ¨ve human cells. Its high fre-
quency of recent thymic emigrants has been linked to this
observation. It has been hypothesized that this might play
a role in the immune defense of the neonate. However,
humanmononuclear cellsare known to be less sensitive to
endotoxin. Therefore, in human in vitro models, the
relevance of endotoxin as a confounder could be less
signiﬁcant than in mice.
There are numerous potential confounders that could be
responsible for the measured effects. LPS was an attractive
candidate for a microbial contaminant, because high
amounts were detected in the BLG fraction by limulus
assay. In addition, we could prove its ability to induce
proliferation and cytokine production by spiking allergen
preparations with LPS. LPS is also known to be one of the
naturally occurring ligands of TLR-4, and we could show
that the contaminating fraction (Fig. 6b) binds to TLR-4
and that exposure to the contaminated BLG is of relevance
also in the presence of different pathogen recognition
receptors via the application of a TLR-4 blocking antibody
(Fig. 6c). Nevertheless, the presence of additional biasing
factors, such as endotoxins from Gram-positive bacteria
Fig. 6. BLG related release of pro-inﬂammatory cytokines is induced by high molecular contaminants and TLR 4 dependent. Human embryonic kidney
cells (HEK293), stablytransfected with an expression vector for human CD14 andTLR4 (293-hCD14/TLR4) and CD14 and TLR2 (293-hCD14/TLR2), were
stimulated with the indicated preparations. The concentration of IL-8 in the supernatant was used as the read-out parameter and measured by ELISA
(Endogene Thermo Scientiﬁc, IL, USA) according to the manufacturer’s instructions (n=4, two independent experiments; a and b). The relevance of this
TLR 4 mediated effect in an in vitro cord blood system with all innate immunity receptors co-expressed was supported by inhibition assays with anti-
TLR4 antibodies. Initially TLR 4- antibody or the respective isotype control [IgG2a, (1mg/mL)] was added for 1h. Thereafter allergens (BLG [LF], Ara h1,
BLG [NP] and fractions from the size exclusion experiments, see Fig. 5) and the positive control [LPS ultra pure, Salmonella minnesota R 595 (0.1mg/
mL)] were added. TNF-a production was measured in the supernatant. Dots represent data from six independent experiments. Sub-fractions generated
via size exclusion chromatography were applied. The high molecular weight fraction (F1; c) acted via TLR4 while the putative BLG-dimer (F5) did not
induce TNF-a production (c). BLG, b lactoglobulin; HEK, human embryonic kidney; LPS, lipopolysaccharide; TLR, toll-like receptor.
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not LPS-related cannot be excluded. However, in our
setting, LPS was the main contaminant within the BLG-
preparations. This has been conﬁrmed by the spiking
experiments and by the TLR-4 inhibition experiments.
Importantly, puriﬁed BLG was capable of inducing
proliferation in CB cells and led to a high percentage of
positive responses comparable to previously published
data [14, 15, 25, 27]. This strengthens the hypothesis that
the measured proliferation in CB is also induced by the
allergen itself, thus reﬂecting allergen speciﬁcity.
None of the investigated CB samples responded to rBet
v 1. This strongly argues for a tolerable degree of
contamination in case of Bet v 1 because the CB related
responses to LPS are easier to induce. Regarding allergen
speciﬁc response to inhalant allergens in CB a possible
explanation could be that intra-uterine priming rather
occurs with food allergens than with inhalant allergens.
Food allergens are present at high concentrations in
maternal PB and can cross the placenta [20]. The amount
of inhaled birch pollen allergens by contrast is considered
rather low and makes intrauterine priming less likely. This
also helps to understand why the time-point of birth
(within or outside the pollen season) does not correlate
with the rate of proliferative response in CB [7]. On the
other hand, recent studies have clearly pointed out that
allergen-speciﬁc proliferation to inhalant allergen does
also occur in CB but at lower frequencies [25, 27]. The
sample size used in our study could have been too small to
detect birch pollen speciﬁc proliferation.
In PBMCs from adult non-allergic donors in contrast,
little or no proliferation in response to the puriﬁed BLG
was measurable. Endotoxin-related effects occurred at a
later time-point and were less prominent. However this
impact is also considerable in case of recall responses as
demonstrated for the spiking experiment with the tt.
Recombinant allergens and antigens display an impor-
tant feature of immunological research. Although endo-
toxin-free conditions are very difﬁcult to achieve due to
the expression system in Escherichia coli, preparations
with low levels of LPS are available. This is the case for
rBet v 1 used in the present publication. Our data suggest
that contaminations up to 20pg/mL as measured in
puriﬁed recombinant allergen preparations are acceptable
because they did not affect proliferative responses sig-
niﬁcantly. While in our study no proliferative response to
rBet v 1 was observed in CB, three out of six non-allergic
adults responded to rBet v 1. This observation, however, is
in line with data of Ebner et al. [28] demonstrating
allergen-speciﬁc proliferation of PBMC also from non-
allergic individuals .
Our data highlight the difﬁculty of differentiating
between allergen-speciﬁc and unspeciﬁc responses in
in vitro cellular assays. The effects highly depend on the
cellular system (cord vs. adult blood cells) and the read
out assay (proliferation, cytokine production). While CB-
derived mononuclear cells readily respond at day 3 to
both contamination and antigen at very low levels, this is
not the case in PBMCs from adult donors. Consequently,
proliferation data should be interpreted with caution,
especially concerning positive responses of CMBC to low
antigen concentrations.
In conclusion, we were able to demonstrate that en-
dotoxins in commercially available allergen preparations
act as a confounder on cellular responses via a TLR4-
dependent mechanism. The impact of these contaminants
on antigen-speciﬁc proliferation are dose- and time-
dependent, as well as dependent on the type of allergen
used and the regulatory properties related to the maturity
of the donor system.
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